Transglutaminase and cell-survival signaling

Progress in Experimental Tumor Research

Volumn 38, Issue , 2005, Pages 75-88

  Singh, Ugra S ^a,b   Pan, Jing ^a  

^a TEXAS A AND M UNIVERSITY SYSTEM   (United States)

^b Cardiovascular Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSGLUTAMINASE 2;

ANIMAL; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOLOGY; ENZYMOLOGY; HUMAN; MOUSE; NERVE CELL; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; GTP-BINDING PROTEINS; HUMANS; MICE; MODELS, BIOLOGICAL; NEURONS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TRANSGLUTAMINASES;

EID: 14544304578     PISSN: 00796263     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000084234     Document Type: Review

References (100)

1. Folk JE, Park MH, Chung SI, Schrode J, Lester EP, Cooper HL: Polyamines as physiological substrates for transglutaminases. J Biol Chem 1980;255:3695-3700.
2. Lorand L, Graham RM: Transglutaminases: Crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003;4:140-156.
3. Greenberg CS, Birckbichler PJ, Rice RH: Transglutaminases: Multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991;5:3071-3077.
4. Aeschlimann D, Kaupp O, Paulsson M: Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: Identification of osteonectin as a major glutaminyl substrate. J Cell Biol 1995;129:881-892.
5. Boehm JE, Singh U, Combs C, Antonyak MA, Cerione RA: Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J Biol Chem 2002;277:20127-20130.
6. Bungay PJ, Owen RA, Coutts IC, Griffin M: A role for transglutaminase in glucose-stimulated insulin release from the pancreatic beta-cell. Biochem J 1986;235:269-278.
7. Akimov SS, Belkin AM: Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 2001;98:1567-1576.
8. Singh US, Pan J, Kao YL, Joshi S, Young KL, Baker KM: Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y Cells. J Biol Chem 2003;278:391-399.
9. Tucholski J, Lesort M, Johnson GV: Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience 2001;102:481-491.
10. Johnson TS, Knight CR, el-Alaoui S, Mian S, Rees RC, Gentile V, Davies PJ, Griffin M: Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth. Oncogene 1994;9:2935-2942.
11. Bernassola F, Federici M, Corazzari M, Terrinoni A, Hribal ML, De Laurenzi V, Ranalli M, Massa O, Sesti G, McLean WH, Citro G, Barbetti F, Melino G: Role of transglutaminase 2 in glucose tolerance: Knockout mice studies and a putative mutation in a MODY patient. FASEB J 2002;16: 1371-1378.
12. Walther DJ, Peter JU, Winter S, Holtje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, Bader M: Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 2003;115:851-862.
13. Folk JE, Chung SI: Transglutaminases. Methods Enzymol 1985;113:358-375.
14. Singh US, Erickson JW, Cerione RA: Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei. Biochemistry 1995;34:15863-15871.
15. Kufe DW, Griffin J, Mitchell T, Shafman T: Polyamine requirements for induction of HL-60 promyelocyte differentiation by leukocyte-conditioned medium and phorbol ester. Cancer Res 1984;44:4281-4284.
16. Sugiura M, Shafman T, Mitchell T, Griffin J, Kufe D: Involvement of spermidine in proliferation and differentiation of human promyelocytic leukemia cells. Blood 1984;63:1153-1158.
17. Cordella-Miele E, Miele L, Beninati S, Mukherjee AB: Transglutaminase- catalyzed incorporation of polyamines into phospholipase A2. J Biochem (Tokyo) 1993;113:164-173.
18. Lee KN, Arnold SA, Birckbichler PJ, Patterson MK Jr, Fraij BM, Takeuchi Y, Carter HA: Site-directed mutagenesis of human tissue transglutaminase: Cys-277 is essential for transglutaminase activity but not for GTPase activity. Biochim Biophys Acta 1993;1202:1-6.
19. Liu S, Cerione RA, Clardy J: Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci USA 2002;99:2743-2747.
20. Pedersen LC, Yee VC, Bishop PD, Le Trong I, Teller DC, Stenkamp RE: Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules. Protein Sci 1994;3:1131-1135.
21. Autuori F, Farrace MG, Oliverio S, Piredda L, Piacentini M: 'Tissue' transglutaminase and apoptosis. Adv Biochem Eng Biotechnol 1998;62:129-136.
22. Melino G, Piacentini M: 'Tissue' transglutaminase in cell death: A downstream or a multifunctional upstream effector? FEBS Lett 1998;430:59-63.
23. Ridley AJ: Rho: Theme and variations. Curr Biol 1996;6:1256-1264.
24. Bourne HR, Sanders DA, McCormick F: The GTPase superfamily: Conserved structure and molecular mechanism. Nature 1991;349:117-127.
25. Symons M: Rho family GTPases: The cytoskeleton and beyond. Trends Biochem Sci 1996;21:178-181.
26. Wittinghofer A, Nassar N: How Ras-related proteins talk to their effectors. Trends Biochem Sci 1996;21:488-491.
27. Wei Y, Zhang Y, Derewenda U, Liu X, Minor W, Nakamoto RK, Somlyo AV, Somlyo AP, Derewenda ZS: Crystal structure of RhoA-GDP and its functional implications. Nat Struct Biol 1997;4:699-703.
28. Diekmann D, Hall A: In vitro binding assay for interactions of Rho and Rac with GTPase-activating proteins and effectors. Methods Enzymol 1995;256:207-215.
29. Self AJ, Paterson HF, Hall A: Different structural organization of Ras and Rho effector domains. Oncogene 1993;8:655-661.
30. Zong H, Kaibuchi K, Quilliam LA: The insert region of RhoA is essential for Rho kinase activation and cellular transformation. Mol Cell Biol 2001;21:5287-5298.
31. Boquet P: Bacterial toxins inhibiting or activating small GTP-binding proteins. Ann NY Acad Sci 1999;886:83-90.
32. Flatau G, Lemichez E, Gauthier M, Chardin P, Paris S, Fiorentini C, Boquet P: Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 1997;387:729-733.
33. Rittinger K, Walker PA, Eccleston JF, Smerdon SJ, Gamblin SJ: Structure at 1.65 A of RhoA and its GTPase-activating protein in complex with a transition-state analogue. Nature 1997;389:758-762.
34. Schmidt G, Sehr P, Wilm M, Selzer J, Mann M, Aktories K: Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 1997;387:725-729.
35. Fiorentini C, Fabbri A, Flatau G, Donelli G, Matarrese P, Lemichez E, Falzano L, Boquet P: Escherichia coli cytotoxic necrotizing factor 1 (CNFl), a toxin that activates the Rho GTPase. J Biol Chem 1997;272:19532-19537.
36. Schmidt G, Selzer J, Lerm M, Aktories K: The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity. Cysteine 866 and histidine 881 are essential for enzyme activity. J Biol Chem 1998;273:13669-13674.
37. Singh US, Kunar MT, Kao YL, Baker KM: Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2. EMBO J 2001;20:2413-2423.
38. Bergamini CM, Eckert RL, Ichinose A, Muszbek L, Squerzanti M: Cellular differentiation and death in a renaissance castle. Cell Death Differ 2003;10:262-265.
39. Lechner C, Zahalka MA, Giot JF, Moller NP, Ullrich A: ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci USA 1996;93:4355-4359.
40. Marinissen MJ, Chiariello M, Gutkind JS: Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev 2001;15:535-553.
41. Schoenwaelder SM, Hughan SC, Boniface K, Fernando S, Holdsworth M, Thompson PE, Salem HH, Jackson SP: RhoA sustains integrin alpha IIbbeta 3 adhesion contacts under high shear. J Biol Chem 2002;277:14738-14746.
42. Ahvazi B, Boeshans KM, Steinert PM: Crystal structure of transglutaminase 3 in complex with GMP: Structural basis for nucleotide specificity. J Biol Chem 2004;279:26716-26725.
43. Candi E, Paradisi A, Terrinoni A, Pietroni V, Oddi S, Cadot B, Jogini V, Meiyappan M, Clardy J, Finazzi-Agro A, Melino G: Transglutaminase 5 is regulated by guanine/adenine nucleotides. Biochem J 2004;381(Pt 1):313-319.
44. Nakaoka H, Perez DM, Baek KJ, Das T, Husain A, Misono K, Im MJ, Graham RM: Gh: A GTP-binding protein with transglutaminase activity and receptor signaling function. Science 1994;264:1593-1596.
45. Vezza R, Habib A, FitzGerald GA: Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, Gh. J Biol Chem 1999;274:12774-12779.
46. Baek KJ, Kwon NS, Lee HS, Kim MS, Muralidhar P, Im MJ: Oxytocin receptor couples to the 80 kDa Gh alpha family protein in human myometrium. Biochem J 1996;315:739-744.
47. Feng JF, Readon M, Yadav SP, Im MJ: Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II. Biochemistry 1999;38:10743-10749.
48. Feng JF, Rhee SG, Im MJ: Evidence that phospholipase delta1 is the effector in the Gh (transglutaminase II)-mediated signaling. J Biol Chem 1996;271:16451-16454.
49. Akimov SS, Krylov D, Fleischman LF, Belkin AM: Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 2000;148:825-838.
50. Danen EH, Sonnenberg A: Integrins in regulation of tissue development and function. J Pathol 2003;201:632-641.
51. Belkin AM, Akimov SS, Zaritskaya LS, Ratnikov BI, Deryugina EI, Strongin AY: Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem 2001;276:18415-18422.
52. Gaudry CA, Verderio E, Jones RA, Smith C, Griffin M: Tissue transglutaminase is an important player at the surface of human endothelial cells: Evidence for its externalization and its colocalization with the beta(1) integrin. Exp Cell Res 1999;252:104-113.
53. Lesort M, Attanavanich K, Zhang J, Johnson GV: Distinct nuclear localization and activity of tissue transglutaminase. J Biol Chem 1998;273:11991-11994.
54. Martinez J, Chalupowicz DG, Roush RK, Sheth A, Barsigian C: Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry 1994;33:2538-2545.
55. Turner PM, Lorand L: Complexation of fibronectin with tissue transglutaminase. Biochemistry 1989;28:628-635.
56. Upchurch HF, Conway E, Patterson MK Jr, Maxwell MD: Localization of cellular transglutaminase on the extracellular matrix after wounding: Characteristics of the matrix bound enzyme. J Cell Physiol 1991;149:375-382.
57. Singli US, Cerione RA: Biochemical effects of retinoic acid on GTP-binding Protein/ Transglutaminases in HeLa cells. Stimulation of GTP-binding and transglutaminase activity, membrane association, and phosphatidylinositol lipid turnover. J Biol Chem 1996;271: 27292-27298.
58. Antonyak MA, Boehm JE, Cerione RA: Phosphoinositide 3-kinase activity is required for retinoic acid-induced expression and activation of the tissue transglutaminase. J Biol Chem 2002;277:14712-14716.
59. Antonyak MA, McNeill CJ, Wakshlag JJ, Boehm JE, Cerione RA: Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells. J Biol Chem 2003;278:15859-15866.
60. Mishra S, Murphy LJ: Tissue transglutaminase has intrinsic kinase activity: Identification of transglutaminase 2 as an insulin-like growth factor binding protein-3 kinase. J Biol Chem 2004;279:23863-23868.
61. Antonyak MA, Singh US, Lee DA, Boehm JE, Combs C, Zgola MM, Page RL, Cerione RA: Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J Biol Chem 2001;276:33582-33587.
62. Milakovic T, Tucholski J, McCoy E, Johnson GV: Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J Biol Chem 2004;279:8715-8722.
63. Nanda N, Iismaa SE, Owens WA, Husain A, Mackay F, Graham RM: Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem 2001;276:20673-20678.
64. Stephens P, Grenard P, Aeschlimann P, Langley M, Blain E, Errington R, Kipling D, Thomas D, Aeschlimann D: Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci 2004;117:3389-3403.
65. Park MH: The essential role of hypusine in eukaryotic translation initiation factor 4D (eIF-4D). Purification of eIF-4D and its precursors and comparison of their activities. J Biol Chem 1989;264:18531-18535.
66. Singh US, Li Q, Cerione R: Identification of the eukaryotic initiation factor 5 A as a retinoic acid-stimulated cellular binding partner for tissue transglutaminase II. J Biol Chem 1998;273:1946-1950.
67. Rosorius O, Reichart B, Kratzer F, Heger P, Dabauvalle MC, Hauber J: Nuclear pore localization and nucleocytoplasmic transport of eIF-5A: Evidence for direct interaction with the export receptor CRM1. J Cell Sci 1999;112:2369-2380.
68. Elfgang C, Rosorius O, Hofer L, Jaksche H, Hauber J, Bevec D: Evidence for specific nucleocytoplasmic transport pathways used by leucine-rich nuclear export signals. Proc Natl Acad Sci USA 1999;96:6229-6234.
69. Liu YP, Nemeroff M, Yan YP, Chen KY: Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification. Biol Signals 1997;6:166-174.
70. Xu A, Chen KY: Hypusine is required for a sequence-specific interaction of eukaryotic initiation factor 5A with postsystematic evolution of ligands by exponential enrichment RNA. J Biol Chem 2001;276:2555-2561.
71. Magni P, Beretta E, Scaccianoce E, Motta M: Retinoic acid negatively regulates neuropeptide Y expression in human neuroblastoma cells. Neuropharmacology 2000;39:1628-1636.
72. Beninati S, Nicolini L, Jakus J, Passeggio A, Abbruzzese A: Identification of a substrate site for transglutaminases on the human protein synthesis initiation factor 5A. Biochem J 1995;305(Pt 3):725-728.
73. Beninati S, Gentile V, Caraglia M, Lentini A, Tagliaferri P, Abbruzzese A: Tissue transglutaminase expression affects hypusine metabolism in BALB/c 3T3 cells. FEBS Lett 1998;437:34-38.
74. Shin DM, Jeon JH, Kim CW, Cho SY, Kwon JC, Lee HJ, Choi KH, Park SC, Kim IG: Cell-type specific activation of intracellular transglutaminase 2 by oxidative stress or UV irradiation: Implications of transglutaminase 2 in age-related cataractogenesis. J Biol Chem 2004;279:15032-15039.
75. Caccamo D, Curro M, Cusumano G, Crisafulli G, Lentile R: Excitotoxin-induced changes in transglutaminase during differentiation of cerebellar granule cells. Amino Acids 2004;26:197-201.
76. Lentile R, Caccamo D, Macaione V, Torre V, Macaione S: NMDA-evoked excitotoxicity increases tissue transglutaminase in cerebellar granule cells. Neuroscience 2002;115:723-729.
77. Chen JS, Mehta K: Tissue transglutaminase: An enzyme with a split personality. Int J Biochem Cell Biol 1999;31:817-836.
78. Griffin M, Casadio R, Bergamini CM: Transglutaminases: Nature's biological glues. Biochem J 2002;368:377-396.
79. Chen R, Gao B, Huang C, Olsen B, Rotundo RF, Blumenstock F, Saba TM: Transglutaminase-mediated fibronectin multimerization in lung endothelial matrix in response to TNF-alpha. Am J Physiol Lung Cell Mol Physiol 2000;279:L161-L174.
80. George MD, Vollberg TM, Floyd EE, Stein JP, Jetten AM: Regulation of transglutaminase type II by transforming growth factor-beta 1 in normal and transformed human epidermal keratinocytes. J Biol Chem 1990;265:11098-11104.
81. Johnson K, Hashimoto S, Lotz M, Pritzker K, Terkeltaub R: Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol 2001;159:149-163.
82. Kuncio GS, Tsyganskaya M, Zhu J, Liu SL, Nagy L, Thomazy V, Davies PJ, Zern MA: TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells. Am J Physiol 1998;274:G240-G245.
83. Ritter SJ, Davies PJ: Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter. J Biol Chem 1998;273:12798-12806.
84. Davies PJ, Murtaugh MP, Moore WT Jr, Johnson GS, Lucas D: Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells. J Biol Chem 1985;260:5166-5174.
85. Corcoran J, Shroot B, Pizzey J, Maden M: The role of retinoic acid receptors in neurite outgrowth from different populations of embryonic mouse dorsal root ganglia. J Cell Sci 2000;113(Pt 14):2567-2574.
86. Hunter K, Maden M, Summerbell D, Eriksson U, Holder N: Retinoic acid stimulates neurite outgrowth in the amphibian spinal cord. Proc Natl Acad Sci USA 1991;88:3666-3670.
87. Maden M: Retinoids in nonmammalian embryos. Methods Mol Biol 1999;97:491-509.
88. McCaffery P, Drager UC: Regulation of retinoic acid signaling in the embryonic nervous system: A master differentiation factor. Cytokine Growth Factor Rev 2000;11:233-249.
89. Kastner P, Grondona JM, Mark M, Gansmuller A, LeMeur M, Decimo D, Vonesch JL, Dolle P, Chambon P: Genetic analysis of RXR alpha developmental function: Convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 1994;78:987-1003.
90. Maden M: Retinoid signalling in the development of the central nervous system. Nat Rev Neurosci 2002;3:843-853.
91. Nagy L, Saydak M, Shipley N, Lu S, Basilion JP, Yan ZH, Syka P, Chandraratna RA, Stein JP, Heyman RA, Davies PJ: Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter. J Biol Chem 1996;271:4355-4365.
92. Oliverio S, Amendola A, Di Sano F, Farrace MG, Fesus L, Nemes Z, Piredda L, Spinedi A, Piacentini M: Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol Cell Biol 1997;17:6040-6048.
93. Ou H, Haendeler J, Aebly MR, Kelly LA, Cholewa BC, Koike G, Kwitek-Black A, Jacob HJ, Berk BC, Miano JM: Retinoic acid-induced tissue transglutaminase and apoptosis in vascular smooth muscle cells. Circ Res 2000;87:881-887.
94. Robitaille K, Daviau A, Tucholski J, Johnson GV, Rancourt C, Blouin R: Tissue transglutaminase triggers oligomerization and activation of dual leucine zipper-bearing kinase in calphostin C-treated cells to facilitate apoptosis. Cell Death Differ 2004;11:542-549.
95. Zhang J, Lesort M, Guttmarm RP, Johnson GV: Modulation of the in situ activity of tissue transglutaminase by calcium and GTP. J Biol Chem 1998;273:2288-2295.
96. Lonze BE, Ginty DD: Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002;35:605-623.
97. Lonze BE, Riccio A, Cohen S, Ginty DD: Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron 2002;34:371-385.
98. Mahoney SA, Wilkinson M, Smith S, Haynes LW: Stabilization of neuntes in cerebellar granule cells by transglutaminase activity: Identification of midkine and galectin-3 as substrates. Neuroscience 2000;101:141-155.
99. Andringa G, Lam KY, Chegary M, Wang X, Chase TN, Bennett MC: Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease. FASEB J, 2004;18:932-934.
100. Chun W, Lesort M, Tucholski J, Faber PW, MacDonald ME, Ross CA, Johnson GV: Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells. Neurobiol Dis 2001;8:391-404.